Castle Biosciences, Inc. (CSTL)
Last updated: 2026-10-24 09:17:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Castle Biosciences, Inc. (CSTL) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $33.12, with a market capitalization of $1.01B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.72 to $44.28. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.01B | |
$33.41 | |
$107.69 | |
$2.26 | |
$33.19 | |
152.35K | |
401.51K | |
-- | |
$44.28 | |
$17.72 | |
-- | |
-- |
Castle Biosciences, Inc. (CSTL) Latest Closing Stock Price
Castle Biosciences, Inc. (CSTL) last closed at $33.19 as of 2026-10-23 20:38:00, unchanged from the previous close of $33.19.
During the latest regular trading session, CSTL traded between $2.26 and $107.69, with a volume of 152.35K shares. The closing price was near the lower end and near the middle of its 52-week range.
Castle Biosciences, Inc. (CSTL) 7-Day Stock Price Change
Over the past seven days, Castle Biosciences, Inc. (CSTL) moved from $33.80 to $33.12, representing a decline of 2.01% ($0.68).
The stock traded between $31.67 and $34.72 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 322.66 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CSTL 52-Week Price Position
Position in Range: 58.0%
CSTL is currently trading at $33.12, placing it 58.0% of the way from its 52-week low of $17.72 to its 52-week high of $44.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Castle Biosciences, Inc. (CSTL)?
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Castle Biosciences, Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 1002 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Castle Biosciences, Inc. (CSTL) Stock on MEXC
Eligible investors can buy real shares of Castle Biosciences, Inc. (CSTL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Castle Biosciences, Inc. (CSTL) stock price today?
2.Is CSTL stock going up or down today?
3.What is CSTL pre-market price?
4.What is CSTL after-hours price?
5.Is CSTL stock trading now?
6.Where does CSTL sit relative to its 52-week high and low?
7.What sector is Castle Biosciences, Inc. in?
8.What is Castle Biosciences, Inc.'s market capitalization and where is it listed?
9.How is CSTL valued in terms of P/E ratio and EPS?
10.Does Castle Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
CSTL Stock Calculator
Estimate the value between CSTL shares and USD.
CSTL Shares to USD
1.00 CSTL shares = 33.122 USD
Calculations are estimates based on the latest available price and are for reference only.


